Suppr超能文献

希腊2型糖尿病患者对国家随访方案指南的依从性:GLANCE研究

Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study.

作者信息

Papanas Nikolaos, Elisaf Moses, Kotsa Kalliopi, Melidonis Andreas, Bousboulas Stavros, Bargiota Alexandra, Pagkalos Emmanouel, Doupis John, Ioannidis Ioannis, Avramidis Iakovos, Pappas Angelos C, Karousos Gerasimos, Arvaniti Eleni, Bristianou Magdalini, Pietri Katerina, Karamousouli Eugenia, Voss Bernd, Migdalis Ilias, Tentolouris Nikolaos

机构信息

Diabetes Centre, Second Department of Internal Medicine, University General Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.

Department of Internal Medicine, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece.

出版信息

Diabetes Ther. 2020 Dec;11(12):2887-2908. doi: 10.1007/s13300-020-00935-6. Epub 2020 Oct 3.

Abstract

INTRODUCTION

Physician adherence, or lack therefore, to diabetes care and follow-up guidelines may be linked to the rates of achieving suboptimal glycaemic, blood pressure and lipid targets in people with type 2 diabetes mellitus (T2DM). In this cross-sectional study we evaluated physician adherence to the patient follow-up protocol (PFP) of the 2017 Hellenic Diabetes Association (HDA) guidelines and also assessed glycated haemoglobin (HbA), blood pressure and lipid control achievement rates in the routine care setting in Greece.

METHODS

Eligible subjects were adults with T2DM receiving oral hypoglycaemic agents (OHAs) for ≥ 1 year who had ≥ 2 HbA measurements in the previous year and an HbA target < 7%. Overall adherence at the subject level was defined as the percentage of the 62 HDA PFP items that had been met during the past year.

RESULTS

Between June and December 2018, 601 eligible subjects (54.6% men; mean age 65.2 years; median T2DM duration 5.9 years, of whom 96.5% had ≥ 1 medical condition/comorbidity), were enrolled into the study by 53 hospital- and office-based endocrinologists, internists and general practitioners. The main OHAs prescribed at enrolment were metformin (91.0%), dipeptidyl peptidase-4 inhibitors (60.7%), sodium-glucose co-transporter-2 inhibitors (23.5%) and sulphonylureas (16.3%). Mean overall physician adherence to the PFP was 43.6%. Predictors of greater higher physicans' adherence were female sex (p = 0.026), > 3 medical conditions/comorbidities (p = 0.043) and diabetic complications (p < 0.001). HbA, low-density lipoprotein-cholesterol, systolic/diastolic blood pressure and composite metabolic targets were achieved by 82.1, 57.0, 42.6 and 21.6% of subjects, respectively.

CONCLUSIONS

In Greek routine care, physician adherence to the PFP of the 2017 HDA guidelines is suboptimal. Future efforts should focus on identifying the barriers to an adequate adherence by physicians to the full PFP, with the aim to provide optimal patient care.

摘要

引言

医生对糖尿病护理及后续指南的遵循与否,可能与2型糖尿病(T2DM)患者血糖、血压及血脂未达最佳目标的发生率相关。在这项横断面研究中,我们评估了医生对2017年希腊糖尿病协会(HDA)指南中患者随访方案(PFP)的遵循情况,并在希腊的常规护理环境中评估了糖化血红蛋白(HbA)、血压及血脂控制达标率。

方法

符合条件的受试者为成年T2DM患者,接受口服降糖药(OHAs)治疗≥1年,且上一年有≥2次HbA测量值,HbA目标值<7%。受试者层面的总体遵循情况定义为过去一年中满足的62项HDA PFP项目的百分比。

结果

2018年6月至12月期间,53名医院及门诊的内分泌科医生、内科医生和全科医生招募了601名符合条件的受试者(男性占54.6%;平均年龄65.2岁;T2DM病程中位数为5.9年,其中96.5%患有≥1种疾病/合并症)。入组时开具的主要OHAs为二甲双胍(91.0%)、二肽基肽酶-4抑制剂(60.7%)、钠-葡萄糖协同转运蛋白-2抑制剂(23.5%)和磺脲类药物(16.3%)。医生对PFP的总体平均遵循率为43.6%。医生遵循率较高的预测因素为女性(p = 0.026)、>3种疾病/合并症(p = 0.043)和糖尿病并发症(p < 0.001)。分别有82.1%、57.0%、42.6%和21.6%的受试者实现了HbA、低密度脂蛋白胆固醇、收缩压/舒张压及综合代谢目标。

结论

在希腊的常规护理中,医生对2017年HDA指南PFP的遵循情况欠佳。未来的工作应侧重于找出医生充分遵循完整PFP的障碍,以提供最佳的患者护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbba/7644661/3b1337bb9f3b/13300_2020_935_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验